The methyltransferase MLL4 promotes nonalcoholic steatohepatitis by enhancing NF-κB signaling
Journal of Biological Chemistry · 2024
DOI: 10.1016/j.jbc.2024.107984 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Junekyoung Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Pharmaceutical Sciences, Natural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, South Kore…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Histone-Lysine N-Methyltransferase, Signal Transduction, Mice, Knockout. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korea Health Industry Development Institute, Medical Research Center, Hamad Medical Corporation.
Abstract (Originalsprache)
Non-alcoholic fatty liver disease (NAFLD) is a growing health problem worldwide, ranging from non-alcoholic fatty liver (NAFL) to the more severe metabolic non-alcoholic steatohepatitis (NASH). Although many studies have elucidated the pathogenesis of NAFLD, the epigenetic regulatory mechanism from NAFL to NASH remains incompletely understood. The histone H3 lysine 4 methyltransferase, MLL4 (also called KMT2D), is a critical epigenetic transcriptional coactivator that mediates overnutrition-induced steatosis in mice, but its potential role in the progression of NASH remains largely unknown. Here, we show that mice lacking the one allele of the Mll4 gene are resistant to hepatic steatosis, inflammation, and fibrosis in NASH conditions compared to wild-type controls. Transcriptome analysis of the livers of control and Mll4+/- mice identified pro-inflammatory genes regulated by the nuclear factor kappa B (NF-κB) signaling pathway as major target genes of MLL4. We show that MLL4 binds to p65 and that MLL4 is required for NF-κB transactivation. Myeloid-specific Mll4 knockout mice showed an almost complete block of NASH, while hepatocyte-specific Mll4 knockout mice showed mild inhibition of steatosis. Pro-inflammatory M1 polarization is decreased and anti-inflammatory M2 polarization is increased in liver macrophages from myeloid-specific Mll4 knockout mice. Importantly, we show that histone H3-lysine 4 methylation mediated by the MLL4-complex plays a critical role in promoting the expression of Ccl2 in hepatocytes and M1 marker genes in macrophages. Our results demonstrate that MLL4, through the NF-κB-MLL4 regulatory axis, exacerbates steatohepatitis in the context of an inflammatory response and represents a potential therapeutic target for NASH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Institute of Pharmaceutical Sciences, Natural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, South Korea.
- Department of Food and Nutrition, College of Natural Information Sciences, Dongduk Women's University, Seoul, South Korea.
- Research Institute of Pharmaceutical Sciences, Natural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, South Korea. Electronic address: leeseung@snu.ac.kr.
Förderung
- National Research Foundation of Korea
- Korea Health Industry Development Institute
- Medical Research Center, Hamad Medical Corporation
- Ministry of Health and Welfare
Zitieren
APA
Lee, J., An, H., Kim, C. S., & Lee, S. (2024). The methyltransferase MLL4 promotes nonalcoholic steatohepatitis by enhancing NF-κB signaling. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107984
Vancouver
Lee J, An H, Kim CS, Lee S. The methyltransferase MLL4 promotes nonalcoholic steatohepatitis by enhancing NF-κB signaling. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107984
BibTeX
@article{Lee2024,
author = {Lee, Junekyoung and An, Hyejin and Kim, Chong-Su and Lee, Seunghee},
title = {The methyltransferase MLL4 promotes nonalcoholic steatohepatitis by enhancing NF-κB signaling},
journal = {Journal of Biological Chemistry},
year = {2024},
doi = {10.1016/j.jbc.2024.107984}
}
EUVIMED